Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nephritis, Interstitial | 4 | 2022 | 40 | 1.390 |
Why?
|
| Acute Kidney Injury | 4 | 2020 | 667 | 1.150 |
Why?
|
| Carrier State | 5 | 2020 | 77 | 1.040 |
Why?
|
| Agricultural Workers' Diseases | 3 | 2020 | 15 | 0.850 |
Why?
|
| Nicaragua | 6 | 2024 | 27 | 0.840 |
Why?
|
| Travel | 2 | 2024 | 123 | 0.820 |
Why?
|
| Dengue | 2 | 2024 | 122 | 0.810 |
Why?
|
| RNA, Viral | 3 | 2025 | 565 | 0.810 |
Why?
|
| Dengue Virus | 1 | 2024 | 132 | 0.780 |
Why?
|
| Staphylococcus aureus | 5 | 2020 | 479 | 0.710 |
Why?
|
| Staphylococcal Infections | 5 | 2020 | 569 | 0.710 |
Why?
|
| Sports | 1 | 2022 | 66 | 0.700 |
Why?
|
| Nickel | 1 | 2020 | 24 | 0.680 |
Why?
|
| Trace Elements | 1 | 2020 | 23 | 0.680 |
Why?
|
| Dog Diseases | 5 | 2025 | 59 | 0.640 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2022 | 799 | 0.520 |
Why?
|
| Nasal Cavity | 1 | 2017 | 52 | 0.500 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 229 | 0.440 |
Why?
|
| Cat Diseases | 3 | 2023 | 15 | 0.420 |
Why?
|
| Kidney | 1 | 2017 | 1326 | 0.340 |
Why?
|
| Young Adult | 9 | 2025 | 9929 | 0.290 |
Why?
|
| Pets | 3 | 2025 | 18 | 0.290 |
Why?
|
| HIV Infections | 2 | 2017 | 2048 | 0.270 |
Why?
|
| Glomerular Filtration Rate | 2 | 2020 | 533 | 0.250 |
Why?
|
| Nose | 2 | 2017 | 102 | 0.240 |
Why?
|
| Dogs | 5 | 2025 | 651 | 0.220 |
Why?
|
| Public Health | 3 | 2021 | 280 | 0.220 |
Why?
|
| Athletes | 2 | 2022 | 73 | 0.220 |
Why?
|
| Disease Transmission, Infectious | 2 | 2021 | 85 | 0.210 |
Why?
|
| Serogroup | 1 | 2024 | 63 | 0.210 |
Why?
|
| Adult | 9 | 2025 | 31506 | 0.200 |
Why?
|
| Immunoglobulin M | 1 | 2024 | 216 | 0.200 |
Why?
|
| Houseflies | 1 | 2022 | 3 | 0.190 |
Why?
|
| Muscidae | 1 | 2022 | 2 | 0.190 |
Why?
|
| Humans | 24 | 2025 | 131930 | 0.190 |
Why?
|
| Cockroaches | 1 | 2022 | 6 | 0.190 |
Why?
|
| Cats | 4 | 2025 | 118 | 0.190 |
Why?
|
| Disease Reservoirs | 1 | 2021 | 36 | 0.180 |
Why?
|
| Sports Medicine | 1 | 2021 | 30 | 0.180 |
Why?
|
| Football | 1 | 2021 | 36 | 0.180 |
Why?
|
| Education, Graduate | 1 | 2011 | 19 | 0.180 |
Why?
|
| Risk Management | 1 | 2021 | 68 | 0.170 |
Why?
|
| Contact Tracing | 1 | 2021 | 56 | 0.170 |
Why?
|
| Students, Public Health | 1 | 2010 | 4 | 0.170 |
Why?
|
| Farmers | 1 | 2020 | 13 | 0.170 |
Why?
|
| Universities | 1 | 2021 | 129 | 0.170 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2010 | 18 | 0.170 |
Why?
|
| Disaster Planning | 1 | 2011 | 60 | 0.170 |
Why?
|
| Nails | 1 | 2020 | 21 | 0.170 |
Why?
|
| Endemic Diseases | 1 | 2020 | 59 | 0.170 |
Why?
|
| Male | 13 | 2025 | 64846 | 0.170 |
Why?
|
| Infection Control | 1 | 2021 | 157 | 0.160 |
Why?
|
| Botswana | 2 | 2017 | 76 | 0.160 |
Why?
|
| Risk Factors | 4 | 2018 | 10893 | 0.160 |
Why?
|
| Renal Insufficiency | 1 | 2022 | 254 | 0.160 |
Why?
|
| Middle Aged | 6 | 2025 | 28893 | 0.150 |
Why?
|
| Occupational Exposure | 1 | 2020 | 131 | 0.150 |
Why?
|
| Students | 1 | 2021 | 263 | 0.150 |
Why?
|
| Communicable Disease Control | 1 | 2010 | 140 | 0.150 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 356 | 0.150 |
Why?
|
| Creatinine | 1 | 2020 | 400 | 0.150 |
Why?
|
| Biomarkers | 2 | 2018 | 3373 | 0.150 |
Why?
|
| Prognosis | 2 | 2018 | 5004 | 0.140 |
Why?
|
| Arbovirus Infections | 1 | 2018 | 29 | 0.140 |
Why?
|
| Epidemiological Monitoring | 1 | 2018 | 62 | 0.140 |
Why?
|
| Texas | 6 | 2025 | 3632 | 0.140 |
Why?
|
| Zoonoses | 3 | 2025 | 52 | 0.140 |
Why?
|
| Microscopy, Electron | 1 | 2017 | 341 | 0.130 |
Why?
|
| Prospective Studies | 2 | 2018 | 6526 | 0.130 |
Why?
|
| Crowding | 1 | 2017 | 11 | 0.130 |
Why?
|
| Female | 11 | 2025 | 70607 | 0.130 |
Why?
|
| Pandemics | 2 | 2022 | 1185 | 0.130 |
Why?
|
| Atrophy | 1 | 2017 | 251 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2017 | 424 | 0.130 |
Why?
|
| Early Diagnosis | 1 | 2017 | 198 | 0.130 |
Why?
|
| Antibodies, Viral | 2 | 2025 | 1204 | 0.130 |
Why?
|
| Edema | 1 | 2017 | 144 | 0.130 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2017 | 235 | 0.130 |
Why?
|
| Staphylococcus epidermidis | 1 | 2016 | 40 | 0.120 |
Why?
|
| Fibrosis | 1 | 2017 | 423 | 0.120 |
Why?
|
| Fever | 1 | 2018 | 310 | 0.120 |
Why?
|
| Rural Population | 1 | 2017 | 242 | 0.110 |
Why?
|
| Incidence | 2 | 2021 | 3362 | 0.110 |
Why?
|
| Biopsy | 1 | 2017 | 1288 | 0.110 |
Why?
|
| Disease Outbreaks | 1 | 2015 | 329 | 0.100 |
Why?
|
| Case-Control Studies | 1 | 2020 | 3415 | 0.100 |
Why?
|
| Prevalence | 2 | 2017 | 2656 | 0.100 |
Why?
|
| Inflammation | 2 | 2017 | 1521 | 0.100 |
Why?
|
| Disease Progression | 1 | 2018 | 2222 | 0.090 |
Why?
|
| Genetic Variation | 2 | 2016 | 1579 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 2303 | 0.090 |
Why?
|
| Bacteremia | 1 | 2016 | 428 | 0.090 |
Why?
|
| Longitudinal Studies | 2 | 2025 | 1493 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2018 | 3710 | 0.080 |
Why?
|
| Leukocidins | 1 | 2008 | 38 | 0.070 |
Why?
|
| Exotoxins | 1 | 2008 | 45 | 0.070 |
Why?
|
| Adolescent | 4 | 2025 | 20524 | 0.070 |
Why?
|
| Animals | 7 | 2025 | 34908 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 1830 | 0.070 |
Why?
|
| Aged | 4 | 2025 | 21394 | 0.070 |
Why?
|
| Bacterial Toxins | 1 | 2008 | 176 | 0.070 |
Why?
|
| Mutation | 1 | 2021 | 6245 | 0.070 |
Why?
|
| Community-Acquired Infections | 1 | 2008 | 245 | 0.060 |
Why?
|
| Antibodies, Bacterial | 1 | 2008 | 406 | 0.060 |
Why?
|
| United States | 4 | 2023 | 11619 | 0.060 |
Why?
|
| Family Characteristics | 1 | 2025 | 89 | 0.060 |
Why?
|
| Viral Load | 1 | 2025 | 408 | 0.050 |
Why?
|
| Agrochemicals | 1 | 2022 | 13 | 0.050 |
Why?
|
| Paraquat | 1 | 2022 | 14 | 0.050 |
Why?
|
| Cations | 1 | 2022 | 37 | 0.050 |
Why?
|
| Insect Control | 1 | 2022 | 11 | 0.050 |
Why?
|
| Child, Preschool | 4 | 2025 | 14715 | 0.050 |
Why?
|
| Child | 5 | 2025 | 25756 | 0.040 |
Why?
|
| Basic Reproduction Number | 1 | 2021 | 2 | 0.040 |
Why?
|
| Neutralization Tests | 1 | 2021 | 237 | 0.040 |
Why?
|
| Surge Capacity | 1 | 2010 | 8 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2021 | 179 | 0.040 |
Why?
|
| Nasal Mucosa | 1 | 2020 | 68 | 0.040 |
Why?
|
| Forecasting | 1 | 2021 | 372 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2021 | 5143 | 0.040 |
Why?
|
| Communicable Diseases, Imported | 1 | 2018 | 6 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2021 | 494 | 0.040 |
Why?
|
| Bites and Stings | 1 | 2018 | 27 | 0.040 |
Why?
|
| Chikungunya Fever | 1 | 2018 | 31 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2020 | 413 | 0.030 |
Why?
|
| Infant | 3 | 2018 | 13032 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 500 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2016 | 2850 | 0.030 |
Why?
|
| West Nile Fever | 1 | 2018 | 139 | 0.030 |
Why?
|
| Coinfection | 1 | 2018 | 188 | 0.030 |
Why?
|
| Multilocus Sequence Typing | 1 | 2016 | 62 | 0.030 |
Why?
|
| Saccharum | 1 | 2015 | 12 | 0.030 |
Why?
|
| Curriculum | 1 | 2011 | 763 | 0.030 |
Why?
|
| Sigmodontinae | 1 | 2015 | 44 | 0.030 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2015 | 46 | 0.030 |
Why?
|
| Tropical Climate | 1 | 2015 | 50 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 1161 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2016 | 430 | 0.030 |
Why?
|
| Mexican Americans | 1 | 2015 | 168 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2018 | 8535 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 795 | 0.030 |
Why?
|
| Transcriptome | 1 | 2020 | 1122 | 0.030 |
Why?
|
| Phylogeny | 1 | 2016 | 762 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3735 | 0.030 |
Why?
|
| Communicable Diseases | 1 | 2015 | 159 | 0.030 |
Why?
|
| Exons | 1 | 2015 | 802 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2022 | 4757 | 0.020 |
Why?
|
| Exome | 1 | 2015 | 1087 | 0.020 |
Why?
|
| Genotype | 1 | 2015 | 2703 | 0.020 |
Why?
|
| Virulence Factors | 1 | 2008 | 187 | 0.020 |
Why?
|
| Phenotype | 1 | 2015 | 4538 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 803 | 0.010 |
Why?
|
| Mice | 1 | 2022 | 18534 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 7113 | 0.010 |
Why?
|